ARXIS INC (ARXS)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-11-05
$48.52-3.96%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-11-05
Research Workspace
Put ARXS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisExpectations look high — the market is pricing in about 37% growth a year, above the roughly 23% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskArxis's acquisition-driven growth has to keep compounding to justify the price. Revenue grew 36% year over year in the third quarter. The company also beat earnings estimates by 54%. It trades at 11 times sales versus a 3 times peer median. The market is pricing in more growth than we forecast. A guidance cut after a recent raise would hit credibility hard. Peer multiples imply a price about 42% below where it trades. Our read remains intact. This read is provisional.
Trailing returns as of 2026-11-05. ARXS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering ARXS (as of Nov 2026).
Based on 3 Wall Street analysts offering 12-month price targets for ARXS in the last 4 months.
Continue this research
Compare ARXS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ARXS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-11-05. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put ARXS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Raise and deliver full-year 2026 financial guidance
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Current $48.52
The last 12 months of price, then the range of analyst 12-month targets from today’s $48.52.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
The forecast signals strong future growth and margins, but does not confirm delivery of 2026 guidance.
Advances: Growth through strategic acquisitions
Upgrade indicates confidence in growth through acquisitions.
Advances: Growth through strategic acquisitions
Acquisition aligns with growth strategy and enhances market position.
Advances: Growth through strategic acquisitions
Acquisition aligns with growth through strategic acquisitions objective.
Advances: Growth through strategic acquisitions
Acquisitions support growth strategy and expand market presence.
Advances: Achieve full-year 2026 revenue guidance of $1.86B to $1.88B
Record results and guidance support revenue targets for 2026.
Advances: Achieve full-year 2026 revenue guidance of $1.86B to $1.88B
Positive guidance reinforces confidence in achieving revenue goals.
Acquisition aligns with growth through strategic acquisitions objective.